Evidence map›Paper›PMID 40080095›Full record

ArticleProbiotics and antimicrobial proteins2026

In Vitro and In Silico Assessment of the Probiotic and Technological Potential of Lacticaseibacillus rhamnosus MW019593 Isolated from Algerian Cow's Milk.

Nassim Madi, Amine M Boukerb, Loubna Mekdade, Assia Ikhlef, Asma Meghezzi, Abderrahmane Selmania, Nathalie Connil

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nassim MadiCentre de Recherche en Technologies Agro-Alimentaires, Route de Targa Ouzemmour, Campus Universitaire, 06000, Bejaia, Algeria. nassim.madi@crtaa.univ-bejaia.dz.ORCID 0009-0008-3987-9047
Amine M BoukerbUniv Rouen Normandie, Univ Caen Normandie, Normandie Univ, CBSA UR, 4312, F-76000, Rouen, France.
Loubna MekdadeBiotechnology Research Center (C.R.Bt.), Ali Mendjli Nouvelle Ville UV 03, BP E73, 25000, Constantine, Algeria.
Assia IkhlefBiotechnology Research Center (C.R.Bt.), Ali Mendjli Nouvelle Ville UV 03, BP E73, 25000, Constantine, Algeria.
Asma MeghezziBiotechnology Research Center (C.R.Bt.), Ali Mendjli Nouvelle Ville UV 03, BP E73, 25000, Constantine, Algeria.
Abderrahmane SelmaniaBiotechnology Research Center (C.R.Bt.), Ali Mendjli Nouvelle Ville UV 03, BP E73, 25000, Constantine, Algeria.
Nathalie ConnilUniv Rouen Normandie, Univ Caen Normandie, Normandie Univ, CBSA UR, 4312, F-76000, Rouen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the in vitro and in silico probiotic potential and technological characteristics of Lacticaseibacillus rhamnosus MW019593 isolated from Algerian cow's milk. Safety was verified by the absence of hemolytic activity, biogenic amine production, and antibiotic sensitivity. Functional probiotic properties of L. rhamnosus MW019593 included moderate inhibition of gastrointestinal pathogens such as Salmonella, Listeria, Clostridioides, and Escherichia coli, tolerance to pH 2-3 and up to 1% bile salts, 46.4% hydrophobicity, 42.4% autoaggregation, and 12.9% adhesion to Caco-2/TC7 cells without cytotoxicity. The ability to form biofilms with a thickness of 23.7 µm, comparable to L. rhamnosus ATCC 53103, was observed using confocal microscopy. Technologically, L. rhamnosus MW019593 and ATCC 53103 showed similar growth profiles and biomass yields, reaching approximately 5 × 10

Indexed as

Lacticaseibacillus rhamnosusMilkProbioticsAlgeriaAnimalsAnti-Bacterial AgentsBacterial AdhesionBiofilmsCaco-2 CellsCattleHumansAnti-Bacterial AgentsAdhesionBiofilmsBiomass yieldGastrointestinal toleranceLacticaseibacillus rhamnosusWGS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.